1.Coats EA, Shah KJ, Milstein SR, Genther CS, Nene DM, Roesener J, Schmidt J, Pleiss M, Wagner E, Baker JK.. (1982) 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cell respiration. 2. Quantitative structure-activity relationship of dehydrogenase enzyme and Ehrlich ascites tumor cell inhibitions., 25 (1):[PMID:7086823][10.1021/jm00343a011]
2.Golub AG, Yakovenko OY, Bdzhola VG, Sapelkin VM, Zien P, Yarmoluk SM.. (2006) Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2., 49 (22):[PMID:17064064][10.1021/jm050048t]
3.Li GX, Liu ZQ, Luo XY.. (2010) Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA., 45 (5):[PMID:20122762][10.1016/j.ejmech.2010.01.018]
4.Shah KJ, Coats EA.. (1977) Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration., 20 (8):[PMID:894670][10.1021/jm00218a003]
5.Helgren TR, Seven ES, Chen C, Edwards TE, Staker BL, Abendroth J, Myler PJ, Horn JR, Hagen TJ.. (2018) The identification of inhibitory compounds of Rickettsia prowazekii methionine aminopeptidase for antibacterial applications., 28 (8):[PMID:29551481][10.1016/j.bmcl.2018.03.002]
6.Mori S, Iinuma H, Manaka N, Ishigami-Yuasa M, Murayama T, Nishijima Y, Sakurai A, Arai R, Kurebayashi N, Sakurai T, Kagechika H.. (2019) Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay., 179 [PMID:31299492][10.1016/j.ejmech.2019.06.076]
7.Zhang H, Daněk O, Makarov D, Rádl S, Kim D, Ledvinka J, Vychodilová K, Hlaváč J, Lefèbre J, Denis M, Rademacher C, Ménová P.. (2022) Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold., 13 (6.0):[PMID:35707152][10.1021/acsmedchemlett.2c00067]